Quantifying the contribution of modifiable risk factors for progression of MGUS to multiple myeloma in a Veteran population
International Journal of Cancer · 01.08.2026 · 159 (3) · 618-628
DOI: 10.1002/ijc.70412 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Cancer, online erschienen am 11.03.2026. Verfasst von Mei Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Research Service, St. Louis Veterans Affairs Medical Center, St. Louis, Missouri, USA. Hauptthemen laut MEDLINE: Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance, Veterans. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIH HHS, Fundation for Barnes-Jewish Hospital.
Abstract (Originalsprache)
Multiple myeloma (MM) is the most common plasma cell dyscrasia in the United States with tremendously high burden. MM is preceded by a premalignant condition, monoclonal gammopathy of undetermined significance (MGUS). Although several risk factors for progression have been identified (e.g., older age, male sex, black race, obesity, chemical exposure), their relative contributions remain unclear. Unlike other malignancies, such evidence is lacking for MM despite its high burden. To identify potential intervention strategies that can effectively prevent progression in patients with MGUS, we quantified contributions of the identified modifiable risk factors in the United States Veteran population with MGUS. Compared to the general population, this population is particularly vulnerable to MM as its higher proportions of male and older age as well as the potential prior Agent Orange exposure. We conducted a retrospective cohort study in the Veterans Health Administration and calculated multivariable‐adjusted population attributable fractions (aPAFs) of progression accounting for competing risk of death. The aPAF estimates the proportion of progression burden in the population with MGUS that is statistically attributable to a specific risk factor, independent of other factors. In the cohort of 35,073 Veterans with MGUS, among all evaluated risk factors (both modifiable and non‐modifiable), excess body mass index (BMI ≥25 kg/m 2 ) was the leading factor (Black: aPAF = 27.1%, 95% CI 19.5%–34.0%; White: 27.2%, 95% CI 20.3%–33.4%; All: aPAF = 27.1%, 95% CI 22.1%–31.9%). Our study highlights the potential of weight management and lifestyle modification for informing the design of targeted MM prevention strategies for Veterans diagnosed with MGUS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Research Service, St. Louis Veterans Affairs Medical Center, St. Louis, Missouri, USA.
- Division of Biology and Biomedical Sciences, Washington University School of Medicine, St. Louis, Missouri, USA.
- Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri, USA.
- Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA.
- City of Hope Comprehensive Cancer Center, Duarte, California, USA.
- Division of Hematology and Medical Oncology, Department of Internal Medicine, Saint Louis University School of Medicine, St. Louis, Missouri, USA.
ORCID-Profile: Mei Wang, Byron Sigel, Lawrence Liu, John H Huber, Mengmeng Ji, Martin W Schoen, Kristen M Sanfilippo, Graham A Colditz, Sylvia H Hsu, Shi-Yi Wang
Förderung
- NCI NIH HHS
- NIH HHS
- Fundation for Barnes-Jewish Hospital
- Alvin J. Siteman Cancer Center
- National Institutes of Health
Zitieren
APA
Wang, M., Sigel, B., Liu, L., Huber, J. H., Ji, M., Schoen, M. W., Sanfilippo, K. M., Thomas, T. S., Colditz, G. A., Hsu, S. H., Wang, S. Y., & Chang, S. H. (2026). Quantifying the contribution of modifiable risk factors for progression of MGUS to multiple myeloma in a Veteran population. International Journal of Cancer, 159(3), 618-628. https://doi.org/10.1002/ijc.70412
Vancouver
Wang M, Sigel B, Liu L, Huber JH, Ji M, Schoen MW, et al. Quantifying the contribution of modifiable risk factors for progression of MGUS to multiple myeloma in a Veteran population. International Journal of Cancer. 2026;159(3):618-628. doi:10.1002/ijc.70412
BibTeX
@article{Wang2026,
author = {Wang, Mei and Sigel, Byron and Liu, Lawrence and Huber, John H and Ji, Mengmeng and Schoen, Martin W and Sanfilippo, Kristen M and Thomas, Theodore S and Colditz, Graham A and Hsu, Sylvia H and Wang, Shi-Yi and Chang, Su-Hsin},
title = {Quantifying the contribution of modifiable risk factors for progression of MGUS to multiple myeloma in a Veteran population},
journal = {International Journal of Cancer},
year = {2026},
volume = {159},
number = {3},
pages = {618--628},
doi = {10.1002/ijc.70412}
}
EUVIMED